Balance Sheet Data
Vertex Pharmaceuticals Incorporated (VRTX)
$349.52
+2.48 (+0.71%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 3,168.24 | 3,808.29 | 6,658.90 | 7,524.90 | 10,778.50 | 12,270.33 | 16,124.13 | 21,188.31 | 27,843.01 | 36,587.79 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 409.69 | 633.52 | 885.35 | 1,136.80 | 1,442.20 | 1,738.88 | 2,285.01 | 3,002.68 | 3,945.74 | 5,185 |
| Account Receivables (%) | ||||||||||
| Inventories | 124.36 | 167.50 | 280.78 | 353.10 | 460.60 | 526.88 | 692.37 | 909.82 | 1,195.57 | 1,571.07 |
| Inventories (%) | ||||||||||
| Accounts Payable | 110.99 | 87.61 | 155.14 | 195 | 303.90 | 333.85 | 438.70 | 576.48 | 757.54 | 995.47 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -95.52 | -75.45 | -259.80 | -235 | -204.70 | -340.99 | -448.09 | -588.82 | -773.75 | -1,016.77 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.